15 Jul 2021

Webinar: Trends and Advances in Patient Centric Drug Development

Catch up on the latest trends and developments in patient centric drug development There is an emerging need for patient centric drug development, and in this recent webinar, Donald Loveday, Global Business Development Manager, SPI Pharma and Doug Hovey, Technical Development Manager, North America, SPI Pharma define patient centricity and discuss its impact on the drug development cycle. They also review the current standard practices in drug development, identify the unmet needs in patient populations that result, and discuss emerging regulatory requirements and the implications for scientists and executives involved in drug development.

Content provided by our supplier

SPI Pharma

  • US
  • 2015
    On CPHI since

Other Content from SPI Pharma (4)